Medication Therapy Management (MTM): The Future of Clinical Pharmacy, How Pharmacists Get Paid to Manage Patient's Chronic Diseases.

Medication Therapy Management (MTM): The Future of Clinical Pharmacy, How Pharmacists Get Paid to Manage Patient’s Chronic Diseases.

by

Medication Therapy Management (MTM) is changing how pharmacy care is delivered and paid for. It moves pharmacists beyond dispensing into ongoing, accountable care for people with chronic diseases. This article explains what MTM is, why it matters, and the practical ways pharmacists get paid to manage diabetes, hypertension, COPD, heart failure, and more. It also shows how to set up a billable service that fits real-world clinic or community workflows.

What MTM Is (and Isn’t)

MTM is a structured set of clinical services that optimize medication use and improve health outcomes. It is not a quick counseling moment at pickup. It is a deliberate process with assessment, a care plan, and follow-up.

Why this matters: Most chronic disease harm comes from nonadherence, drug interactions, poor selection, or wrong doses. MTM addresses those risks every time, with documentation and accountability.

Why MTM Matters for Patients and Payers

  • Reduces avoidable harm: Polypharmacy, high-risk meds, and organ impairment drive adverse drug events. A pharmacist’s systematic review finds and fixes these.
  • Improves control of chronic diseases: Insulin titration, statin optimization, and inhaler technique are typical high-yield MTM tasks. Better control cuts ER visits and admissions.
  • Saves costs: Fewer complications and better adherence lower total cost of care. Plans reward MTM because it protects their quality ratings and budgets.
  • Closes quality gaps: MTM supports measures like A1c control, statin use in diabetes, blood pressure control, and medication adherence. These measures drive payer bonuses.

What MTM Includes

  • Comprehensive Medication Review (CMR): A full assessment of all prescriptions, OTCs, herbals, and supplements. Identifies problems, sets goals, and creates an action plan. Requires documentation and patient-friendly takeaways.
  • Targeted Medication Reviews (TMR): Focused, shorter interventions for specific gaps (e.g., overdue lab, missing statin, refill lapses). Done quarterly or as needed.
  • Care plan and follow-up: A written plan with monitoring, dose changes, and next steps. Follow-up ensures the plan actually happens.
  • Coordination: Communication with prescribers, caregivers, and the health team to resolve problems and implement changes.

Why these pieces: Chronic care is not a one-and-done event. Without follow-up and coordination, even good recommendations fail in practice.

How Pharmacists Get Paid for MTM

There are multiple payment paths. Your model depends on your setting, contracts, and state rules.

1) Medicare Part D MTM Programs (Pharmacy Benefit)

Part D plans must offer MTM to eligible members who have multiple chronic diseases, take several Part D medications, and exceed an annual drug spend threshold. Plans pay pharmacists to complete MTM through direct contracts or MTM vendor platforms.

  • Core deliverables: One annual CMR and quarterly TMRs. Provide a Personal Medication List (PML) and Medication Action Plan (MAP).
  • Payment: Usually a flat fee per completed case. Typical ranges:
    • CMR: about $50–$150 depending on plan complexity and market.
    • TMR or discrete interventions: about $10–$50 each.

    Rates vary widely by payer and region.

  • Why plans pay: CMR completion and adherence affect Medicare Star Ratings. Higher Stars mean bonuses and enrollment advantages for plans.

Practical note: Pharmacists enroll with MTM platforms, complete training, and accept cases. Efficient scheduling and templated documentation drive margin.

2) Medical-Benefit Billing via “Incident-To” (Team-Based Care)

At the federal level, pharmacists generally are not recognized as Medicare Part B providers. But pharmacists can furnish many services as clinical staff “incident to” a physician or qualified practitioner. The physician bills the codes; the pharmacist performs much of the work under required supervision.

  • Chronic Care Management (CCM): Monthly care for patients with ≥2 chronic conditions. Codes allow clinical staff time under general supervision. Pharmacists can deliver medication management, reconcile meds after transitions, and coordinate labs.
    • Typical codes: 99490, 99439 (clinical staff time, 20+ minutes per month and add-ons).
  • Principal Care Management (PCM): Monthly care for a single serious condition (e.g., diabetes with complications). Pharmacists can run meds and monitoring under a care plan.
    • Typical codes: 99426, 99427 (clinical staff time).
  • Remote Patient Monitoring (RPM) and Remote Therapeutic Monitoring (RTM): Device-based or therapy-based monitoring with monthly management time. Pharmacists often manage titration protocols and adherence under general supervision.
    • Typical codes: 99453, 99454, 99457, 99458 (RPM); 98975, 98976/98977, 98980, 98981 (RTM).
  • Behavioral Health Integration (BHI): For conditions like depression and anxiety within primary care. Pharmacists can support med adjustments and adherence as clinical staff.
  • Transitional Care Management (TCM): After hospital discharge. Pharmacists complete med reconciliation and address high-risk meds as part of the team’s billed service.

Why this works: These codes pay for exactly what pharmacists do best—ongoing management, monitoring, and coordination. They scale with panel size and embed pharmacists in the care team.

Key reminder: Supervision level, documentation, and consent rules apply. Local payer policies differ. Build workflows that meet the code requirements.

3) State Medicaid and Commercial Payers

Some state Medicaid programs and commercial plans reimburse MTM directly when pharmacists bill using MTM-specific CPT codes:

  • 99605: Initial MTM service, new patient, up to 15 minutes.
  • 99606: Initial MTM service, established patient, up to 15 minutes.
  • 99607: Each additional 15 minutes.

Rates and policies vary. Some states also grant pharmacists “provider status,” letting them enroll, credential, and bill for defined clinical services. Confirm scope, covered services, and documentation requirements in your state.

4) Value-Based Contracts, ACOs, and Employers

In accountable care organizations (ACOs) and shared-savings models, pharmacists are funded through care management budgets. Payment is tied to outcomes like reduced admissions, better A1c control, or improved adherence.

  • Models: Per-member-per-month (PMPM) for panel management, quality bonuses, or shared savings.
  • Why it works: Pharmacist-driven medication optimization yields measurable savings and better quality scores.

Collaborative Practice Agreements (CPAs): The Engine Behind Clinical Impact

CPAs let pharmacists initiate, modify, or discontinue medications under agreed protocols. This is crucial for chronic disease management because it allows timely adjustments without extra office visits.

  • Examples: Insulin titration to fasting glucose targets; ACE inhibitor initiation for albuminuric CKD; statin optimization for diabetes; inhaler step-up/step-down based on symptoms and spirometry.
  • Why CPAs matter: Faster changes mean better outcomes and fewer emergencies. They also justify value-based payments and support medical-benefit billing workflows.

Documentation That Gets You Paid

  • Use a structured note: Problem list, assessment, plan, education, and follow-up. Document time spent for time-based codes.
  • Include patient-facing tools: Personal Medication List and Medication Action Plan for CMRs. Plain language and clear next steps.
  • Track quality measures: A1c, BP, LDL, refill gaps, and high-risk meds in older adults. Payers reward measurable change.
  • Interoperability: Use the Pharmacist eCare Plan standard or FHIR-based tools so your data flows to payers and care teams.

Setting Up a Billable Pharmacist Service

  • Choose your payment path: Part D MTM platform, incident-to medical billing via a clinic, state Medicaid/commercial MTM billing, or value-based contracts.
  • Define your panel: Start with high-risk patients (e.g., A1c >9%, heart failure, COPD frequent exacerbations, polypharmacy, high-cost spenders).
  • Secure authority: Draft CPAs that cover common titrations and monitoring. Align with clinic protocols and state law.
  • Map workflow: Intake, consent (for CCM/PCM/RPM as required), visit cadence, labs, communication with prescribers, and documentation templates.
  • Train the team: Medical assistants and technicians can handle data prep, vitals, device setup, and scheduling. Preserve pharmacist time for clinical decisions.
  • Measure and report: Build dashboards for adherence, A1c, BP, ED visits, and CMR completion rate. Share results with payers to strengthen contracts.

Revenue Scenarios (Realistic Examples)

  • Community pharmacy, Part D MTM: 50 CMRs/month at $90 average = $4,500. Add 150 TMRs at $20 = $3,000. Total ≈ $7,500/month. Efficiency matters: pre-visit data pulls and templated MAPs shorten time per case.
  • Clinic-based pharmacist, CCM + PCM: 200 eligible patients, average 30 minutes of clinical staff time per month. With code combinations and typical payer mixes, net revenue often supports 1.0 FTE pharmacist plus benefits. The “why”: monthly care management payments are recurring and predictable.
  • RPM for hypertension: 120 patients on connected cuffs. Pharmacist reviews data, adjusts meds under CPA, and documents 20 minutes per patient per month. Combined technical and management fees (billed by the physician) can fund pharmacist time and devices while improving BP control.

Common Pitfalls and How to Avoid Them

  • Weak documentation: Missing time logs, consent, or care plan details leads to denials. Fix with standard templates and checklists.
  • No follow-up cadence: One-time reviews do not change outcomes. Put patients on a schedule (monthly for complex cases).
  • Unclear roles: If the team does not know who adjusts meds or orders labs, delays happen. CPAs and standing orders solve this.
  • Chasing every code: Pick 1–2 billing pathways and master them before adding more. Complexity without scale kills margin.
  • Ignoring state laws: Scope of practice and supervision rules vary. Align services and billing with local regulations.

Quality and Compliance Essentials

  • HIPAA and consent: Obtain and document consent for CCM/PCM/RPM and for sharing data with plans.
  • Medication safety first: Prioritize high-risk drugs, renal/hepatic dosing, and drug–drug interactions for every review.
  • Patient education: Use teach-back. Demonstrate devices and inhalers. Explain “why” so patients stick with the plan.
  • Equity focus: Screen for cost barriers and literacy. Switch to affordable regimens and simplify dosing to improve adherence.

The Future of Clinical Pharmacy

MTM is shifting from a standalone task to a continuous care model tied to outcomes. Expect more state-level provider recognition, broader CPAs, and deeper integration with primary care, behavioral health, and specialty teams. Digital tools will amplify pharmacist reach through remote monitoring, algorithm-guided titrations, and data-driven risk targeting.

The throughline is simple: payers want fewer complications, better control, and proof. Pharmacists deliver that by owning the medication piece end to end—assessment, optimization, monitoring, and follow-up. Build the service, document the work, and choose payment models that match your setting. That is how pharmacists get paid to manage chronic diseases—and how patients get safer, better care.

Leave a Comment